Medical University of South Carolina
Pathology residency · Charleston, SC · Medical University of South Carolina programs · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Medical University of South Carolina's research in pathology, which the program shares with other departments and affiliated hospitals.
Pathology at Medical University of South Carolinashared by every program there, not this program's own
Institution-level: all pathology publications from Medical University of South Carolina and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Pathology research topics at Medical University of South Carolina
Papers in the window; each links to the list on OpenAlex.
Most cited at Medical University of South Carolina since 2024
All pathology papers there on OpenAlex
- Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang et al. · Blood Advances · 2025 · PubMed · cited 7
- Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 studyAlex Francisco Herrera et al. · Blood Advances · 2025 · PubMed · cited 12
- Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826Sarah C. Rutherford et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 36
- Larsucosterol for the Treatment of Alcohol-Associated HepatitisMitchell Shiffman et al. · NEJM Evidence · 2025 · PubMed · cited 18
- From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironmentTaylor S. Hulahan et al. · Journal of Experimental & Clinical Cancer Research · 2024 · PubMed · cited 17
- Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphomaTimothy I. Shaw et al. · Leukemia · 2024 · PubMed · cited 12
- Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre studyKim Linton et al. · The Lancet Haematology · 2024 · PubMed · cited 184
- Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse B. Ercan et al. · The Lancet Oncology · 2024 · PubMed · cited 83
- Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver DiseaseGarth R. Swanson et al. · Clinical and Translational Gastroenterology · 2024 · PubMed · cited 15
- Recommendations on the measurement and use of the alcohol consumption biomarker CDT. A position paper from the IFCC Working Group on CDT standardisationJos P.M. Wielders et al. · Clinica Chimica Acta · 2024 · PubMed · cited 12
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/medical-university-south-carolina-path"><img src="https://openprograms.org/programs/medical-university-south-carolina-path/badge.svg" alt="Medical University of South Carolina Pathology residency on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.